Whitney Barham
Lab Manager
Last active: 10/28/2015

  1. Thymoquinone enhances cisplatin-response through direct tumor effects in a syngeneic mouse model of ovarian cancer. Wilson AJ, Saskowski J, Barham W, Yull F, Khabele D (2015) J Ovarian Res : 46
    › Primary publication · 26215403 (PubMed) · PMC4517540 (PubMed Central)
  2. NF-κB-dependent airway inflammation triggers systemic insulin resistance. Cyphert TJ, Morris RT, House LM, Barnes TM, Otero YF, Barham WJ, Hunt RP, Zaynagetdinov R, Yull FE, Blackwell TS, McGuinness OP (2015) Am J Physiol Regul Integr Comp Physiol 309(9): R1144-52
    › Primary publication · 26377563 (PubMed) · PMC4666958 (PubMed Central)
  3. Biocompatible mannosylated endosomal-escape nanoparticles enhance selective delivery of short nucleotide sequences to tumor associated macrophages. Ortega RA, Barham WJ, Kumar B, Tikhomirov O, McFadden ID, Yull FE, Giorgio TD (2015) Nanoscale 7(2): 500-10
    › Citation · 25408159 (PubMed)
  4. Aberrant activation of NF-κB signaling in mammary epithelium leads to abnormal growth and ductal carcinoma in situ. Barham W, Chen L, Tikhomirov O, Onishko H, Gleaves L, Stricker TP, Blackwell TS, Yull FE (2015) BMC Cancer : 647
    › Primary publication · 26424146 (PubMed) · PMC4590702 (PubMed Central)
  5. Myeloid IKKβ promotes antitumor immunity by modulating CCL11 and the innate immune response. Yang J, Hawkins OE, Barham W, Gilchuk P, Boothby M, Ayers GD, Joyce S, Karin M, Yull FE, Richmond A (2014) Cancer Res 74(24): 7274-84
    › Citation · 25336190 (PubMed) · PMC4349570 (PubMed Central)
  6. IκB kinase activity drives fetal lung macrophage maturation along a non-M1/M2 paradigm. Stouch AN, Zaynagetdinov R, Barham WJ, Stinnett AM, Slaughter JC, Yull FE, Hoffman HM, Blackwell TS, Prince LS (2014) J Immunol 193(3): 1184-93
    › Citation · 24981452 (PubMed) · PMC4108541 (PubMed Central)
  7. Tracking NF-κB activity in tumor cells during ovarian cancer progression in a syngeneic mouse model. Wilson AJ, Barham W, Saskowski J, Tikhomirov O, Chen L, Lee HJ, Yull F, Khabele D (2013) J Ovarian Res 6(1): 63
    › Citation · 24020521 (PubMed) · PMC3846584 (PubMed Central)
  8. Targeting the Wnt pathway in synovial sarcoma models. Barham W, Frump AL, Sherrill TP, Garcia CB, Saito-Diaz K, VanSaun MN, Fingleton B, Gleaves L, Orton D, Capecchi MR, Blackwell TS, Lee E, Yull F, Eid JE (2013) Cancer Discov 3(11): 1286-301
    › Primary publication · 23921231 (PubMed) · PMC3823757 (PubMed Central)
  9. Macrophage-specific RNA interference targeting via "click", mannosylated polymeric micelles. Yu SS, Lau CM, Barham WJ, Onishko HM, Nelson CE, Li H, Smith CA, Yull FE, Duvall CL, Giorgio TD (2013) Mol Pharm 10(3): 975-87
    › Primary publication · 23331322 (PubMed) · PMC3595119 (PubMed Central)
  10. Intraductal injection of LPS as a mouse model of mastitis: signaling visualized via an NF-κB reporter transgenic. Barham W, Sherrill T, Connelly L, Blackwell TS, Yull FE (2012) J Vis Exp (67): e4030
    › Primary publication · 22971993 (PubMed) · PMC3490260 (PubMed Central)